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Abstract
AIM: Despite the presence of lymphocyte infiltration, human
hepatocellular carcinoma (HCC) is typically a rapidly
progressive disease. The mechanism of regulation of
lymphocyte migration is poorly understood. In this study,
we investigated various factors regulating T cell migration
in HCC patients. We examined serum CXC chemokine levels
in HCC patients and demonstrated the production of CXC
chemokines by HCC cell lines. We determined the effect of
both HCC patient serum and tumor cell conditioned
supernatant upon lymphocyte expression of chemokine
receptor CXCR3 as well as lymphocyte migration. Lastly,
we examined the chemotactic responses of lymphocytes
derived from HCC patients.
METHODS: The serum chemokines IP-10 (CXCL10) and
Mig (CXCL9) levels were measured by cytometric bead
array (CBA) and the tumor tissue IP-10 concentration was
measured by ELISA. The surface expression of CXCR3 on
lymphocytes was determined by flow cytometry. The
migratory function of lymphocytes to the corresponding
chemokines was assessed using an in vitro chemotactic
assay. Phosphorylation of extracellular signal-regulated
kinase (ERK) was determined by Western blot analysis.
RESULTS: Increased levels of IP-10 and Mig were detected
in HCC patient serum and culture supernatants of HCC cell
lines. The IP-10 concentration in the tumor was significantly
higher than that in the non-involved adjacent liver tissues.
HCC cell lines secreted functional chemokines that induced
a CXCR3-specific chemotactic response of lymphocytes.
Furthermore, tumor-cell-derived chemokines induced initial
rapid phosphorylation of lymphocyte ERK followed by later
inhibition of ERK phosphorylation. The culture of normal
lymphocytes with HCC cell line supernatants or medium
containing serum from HCC patients resulted in a significant
reduction in the proportion of lymphocytes exhibiting
surface expression of CXCR3. The reduction in T cell
expression of CXCR3 resulted in reduced migration toward
the ligand IP-10, and both CD4+ and CD8+ T cells from HCC
patients exhibited diminished chemotactic responses to
IP-10 in vitro compared to T cells from healthy control subjects.
CONCLUSION: This study demonstrates functional
desensitization of the chemokine receptor CXCR3 in
lymphocytes from HCC patients by CXCR3 ligands secreted
by tumor cells. This may cause lymphocyte dysfunction and
subsequently impaired immune defense against the tumor.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
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INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most common
cancers in the world. The prognosis of patients with HCC is
generally poor because the cancer is characterized by a rapid
growth rate and vascular invasion[1]. T-lymphocyte-mediated
cellular immunity plays an important role in host defense against
tumors. Indeed, the presence of a heavy lymphocyte infiltration
is associated with low recurrence and high survival rates in a
variety of cancers including HCC[2-7] with most of the infiltrating
lymphocytes in HCC being CD8+ or CD4+ T cells[6]. Activated
CD8+ T cells constitute an essential arm of the immune system
for controlling tumor growth[8], and stimulated CD4+ T cells are
critical for successful tumor eradication[9-11]. However, marked
lymphocyte infiltration was only observed in 10-20% cases of
HCC, and the number of tumor-infiltrating lymphocytes (TIL)
in HCC is generally lower than that evident in other cancers[6].
Although the mechanism underlying the regulation of
lymphocyte traffic in patients with HCC is not well characterized,
it is likely to involve a process of regulated adhesion and
migration that requires tethering, triggering, integrin-mediated
adhesion and chemotactic factors[12]. The most important
molecules involved in triggering and directing lymphocyte
migration are chemokines[13]. Lymphocyte migratory pathways
are tightly regulated by chemokine receptor expression and
exposure to chemokines. Lymphocytes could only be recruited
if they express the corresponding chemokine receptors[13].
      Chemokines are 8- to 12-kDa, heparin-binding cytokines
distinguished by the specificity of their chemotactic properties
for target cells[14]. They can be divided into four groups: CC,
CXC, C and CX3C, based on the arrangement of conserved
cysteine residues[15]. The importance of chemokines in regulating
lymphocyte trafficking is suggested by the large number of
chemokines in each of the four chemokine subfamilies that
have been demonstrated to influence lymphocyte behaviors
in vitro[16,17]. IP-10 and Mig, members of the CXC chemokine
family, induce potent lymphocyte chemotaxis following
interaction with their receptor, CXCR3[18,19], and play an important
role in various inflammatory diseases[20-25]. CXCR3 exerts an
important role in the recruitment of lymphocytes to both normal
and diseased tissues[26-29]. However, the role of CXCR3 in the
regulation of lymphocyte traffic in HCC remains unclear.
       In this study, we examined the serum levels of chemokines
IP-10 and Mig in HCC patients together with IP-10 levels in
tumor and adjacent nontumor tissues. We also examined
chemokine production by HCC cell lines and evaluated the
interaction between these chemokines and their receptor
CXCR3 in T lymphocytes. The role of these chemokines and
their corresponding receptor in regulating T cell function in
HCC were addressed in this study.
MATERIALS AND METHODS
Patients and samples
Fresh whole blood and serum samples were obtained from
35 patients (31 men, 4 women; median age 54 years, range
36-84 years) with a diagnosis of HCC. Fresh tumor and peritumor
liver specimens were obtained from 32 patients who underwent
liver resection for HCC.  Fresh whole blood and serum samples
were also obtained from 12 healthy controls (10 men, 2 women;
median age 46 years, range 27-58 years). None of the patients
had received immunosuppressive drugs or chemotherapy. This
study was approved by the Ethics Committee of our institution
and informed consent was given by the patients.
Preparation of lymphocytes
Peripheral blood lymphocytes (PBLs) were isolated by Ficoll-
Hypaque density gradient separation and washed twice in PBS.
Mononuclear cells were suspended in RPMI-1640 medium and
incubated at 37 ℃ for 90 min in a 6-well plate. Non-adherent
lymphocytes were then collected for flow cytometric analysis,
chemotaxis assays and Western blot analysis.
Cell lines
The HCC cell line Hep3B was obtained from the American Type
Culture Collection (ATCC, Rockville, MD, USA) and HuH 7
was provided by Dr H. Nakabayashi (Hokkaido University
School of Medicine, Hokkaido, Japan). Immortalized human
hepatocyte MIHA was provided by Dr Roy Chowdhury (Albert
Einstein College of Medicine, New York, USA). Hep3B and
HuH 7 were cultured in DMEM medium containing penicillin/
streptomycin and L-glutamine supplemented with 10% FCS.
MIHA was cultured in Waymouth’s MB 752/1 medium (Gibco/
BRL) supplemented with 10% FCS, penicillin/streptomycin and
L-glutamine. Culture supernatants were collected from 3-d-old
tumor cell cultures for further experiments.
Cytometric bead array (CBA) for chemokines
The concentrations of IP-10 and Mig in serum and cell culture
supernatants were measured using the human chemokine CBA
kit I (BD PharMingen, San Diego, CA, USA). In brief, 20 L of
mixed chemokine IP-10 and Mig capture beads was mixed with
20 L of serum or culture supernatants and 20 L of PE detection
reagent and incubated for 3 h at room temperature. The beads
were then washed with wash buffer and analyzed by FACS
caliber (Becton Dickinson, San Jose, CA, USA).
Measurement of tumor and non-tumor IP-10 protein concentration
IP-10 of both tumor and adjacent nontumor tissue cytosolic
samples was measured by the Quantikine human IP-10 ELISA
kit (R&D Systems, Minneapolis, MN, USA). Protein fraction
was obtained by homogenization of tissues in lysis buffer (1%
Nonidet, 0.5% sodium deoxycholate, 0.1% SDS, 1 mmol/L PMSF
and protease inhibitor cocktail at 1 tablet per 50 mL extraction
solution). Homogenates were centrifuged at 20 000 g at 4 ℃ for
10 min and the supernatants were collected for assay of IP-10 levels.
Flow cytometry analysis
The following antibodies were used in this study: APC-conjugated
anti-CD4, PerCP-conjugated anti-CD8, phycoerythrin-conjugated
anti-CXCR3 and IgG isotype control (BD PharMingen, San Diego,
CA, USA). Lymphocytes were incubated with the antibodies
for 30 min at 4 ℃, and two-color or three-color flow cytometry
was performed on an FACS caliber analyzer (Becton Dickinson,
San Jose, CA, USA).
Chemotaxis assay
Lymphocyte chemotaxis assay was performed using 5.0-m
pore size Transwell inserts (Corning Costar, Cambridge, MA,
USA). Six hundred mL of tumor culture supernatant, chemokine
IP-10 (100 ng/mL) (PeproTech, London, UK) or medium alone
were added to the lower Transwell chamber. A total of 5×105
PBL in 100 L were added to the upper Transwell chamber
containing 50 mL/L CO2 and incubated for 3 h at 37 ℃. In some
experiments, PBLs were incubated with blocking anti-CXCR3
monoclonal antibodies or isotype control antibody (R&D
Systems, Minneapolis, MN, USA) for 1 h at room temperature
before they were added to the upper chamber of the Transwell.
Migrated cells were collected from the lower chamber after the
lowerside of the filter was carefully washed. Cells were washed
in flow cytometry buffer and then incubated for 30 min at 4 ℃
with APC-conjugated anti-CD4 and PerCP-conjugated anti-CD8.
Cells were then washed and analyzed by flow cytometry with
counting of viable cells for 1 min. Chemotaxis was quantified
by dividing the number of CD4 or CD8 positive cells migrating
in the presence of chemokines by the number of cells migrating
toward the medium alone.
Assessment of chemokine receptor expression on normal PBLs
pretreated with tumor conditioned medium or medium
supplemented by serum derived from HCC patients
Hep3B and HuH-7 were seeded in 24-well plates and incubated
in DMEM medium containing L-glutamine supplemented with
10% FCS for 3 d. The culture supernatants were aspirated and
centrifuged. Freshly isolated normal PBLs from eight healthy
control subjects were incubated with the conditioned
supernatant for 20 h with 3-d MIHA culture medium serving as
control. To determine the effect of the cell supernatants on the
expression of CXCR3 by PBLs, surface CXCR3 expression was
measured by flow cytometry. For the effect of the serum from
HCC patients on lymphocyte CXCR3 expression, normal PBLs
were incubated with either medium with 10% serum from HCC
patients or 10% serum from healthy control subjects for 24 h.
Normal PBLs cultured in the full medium with 10% FCS served
as medium control. Surface expression of CXCR3 was measured
by flow cytometry.
Western blot analysis
Normal PBLs were incubated for 10 min or overnight with cell
culture supernatants or IP-10 at 37 ℃. The cells were collected,
washed twice with PBS, and then lysed in lysis buffer (Cell
signaling, Beverly, MA, USA) for 15 min at 4 ℃. The lysates
were centrifuged at 12 000 g for 15 min at 4 ℃ and equal amounts
of solubilized proteins were separated by SDS-PAGE, and then
transferred to nitrocellulose membranes (Amersham Biosciences,
Piscataway, NJ, USA). The membranes were blocked with TBST
(20 mmol/L Tris, pH 7.6, 135 mmol/L NaCl, 0.1% Tween 20)
containing 5% non-fat milk and immunoblotted with anti-
phosphorylated ERK (1:000) (Cell ignaling, Beverly, MA, USA)
for 18 h at 4 ℃, followed by detection using HRP-conjugated
secondary antibody (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) for 1 h at room temperature. Immunoreactive protein
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bands were visualized by the ECL system (Amersham Biosciences,
Piscataway, NJ, USA).
Statistical analysis
Comparison of continuous variables between unpaired groups
was performed using the Mann-Whitney U test. Wilcoxon’s
rank sum test was used for the analysis of difference between
paired groups. Correlation between continuous variables was
performed using the Spearmann’s correlation coefficient (r). A
P value less than 0.05 was defined as statistically significant.
All statistical analyses were performed using the SPSS
statistical software package (SPSS 10.0 for Windows, SPSS,
Inc, Chicago, IL, USA).
RESULTS
Serum IP-10, Mig and tumor IP-10 levels in HCC patients
Serum IP-10 and Mig levels were significantly elevated in HCC
patients compared with normal healthy subjects (Figure 1). In
HCC patients, serum IP-10 level was significantly correlated
with Mig level (correlation coefficient = 0.631, P<0.0001).
Furthermore, analysis of tissue IP-10 levels indicated that tumor
IP-10 level was significantly higher than that of the adjacent
non-tumor tissues (Figure 2).
HCC tumor cell lines secreted functional chemokines
IP-10 and Mig were also detected in the supernatants of tumor
cells Hep3B and HuH 7 whilst immortalized hepatocytes
produced negligible levels, thereby providing further evidence
that HCC tumor tissue might be a likely source of the elevated
serum levels of chemokines in HCC patients (Figure 3). We
tested the chemotactic effect of tumor cell supernatants upon
normal PBLs. Both CD4+ and CD8+ T cells exhibited a significant
chemotactic response to Hep3B supernatants but not to
supernatants of the control liver cell line MIHA. This chemotactic
response was demonstrated to be CXCR3 specific since pre-
incubation of T cells with a function blocking anti-CXCR3
monoclonal antibody (mAb) significantly reduced both the
CD4+ and CD8+ T cell chemotactic activity of the Hep3B
supernatants compared to isotype control mAb (Figure 4).
Figure 2  Boxplots show significant increase of tumor IP-10
level compared to that of non-tumor liver tissue. Data are
presented as boxplots as medians and the 25th, 75th and 90th
percentiles, n = 32, P<0.001.
       We also studied the effect of tumor cell culture supernatants
on the phosphorylation of ERK in normal PBLs. Stimulation of
normal PBLs for 10 min with tumor cell supernatants but not
immortalized liver cell supernatant induced the transient
Figure 1  Assay of IP-10 and Mig in serum from 35 patients and 12 healthy controls by cytometric bead array analysis. Serum levels
of IP-10 and Mig in patients with HCC were significantly higher than those of healthy controls. Data are presented as boxplots as
medians and the 25th, 75th and 90th percentiles, P<0.05.
Figure 3  Secretion of IP-10 and Mig by HCC cell lines Hep3B and HuH-7, but not by control liver cell line MIHA. Three-day cell
culture supernatants were collected and IP-10, Mig levels were quantified by cytometric bead array analysis. Significantly higher
levels of IP-10 and Mig were detected in HCC cell line supernatants compared with those of control cell line MIHA. Data are
presented as boxplots as medians and the 25th, 75th and 90th percentiles, aP<0.05.
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phosphorylation of ERK. However, prolonged overnight
stimulation of normal PBLs with tumor cell culture supernatants
inhibited ERK phosphorylation. Cells stimulated with IP-10 at
100 nmol/L for 10 min or overnight were included as controls
(Figure 5).
Proportion of CXCR3-expressing T lymphocytes was downregulated
by tumor-conditioned medium and tumor patient serum
Following incubation with medium conditioned by the tumor
cell lines Hep3B and HuH-7 for 20 h, the proportion of CD4+
and CD8+ T cells from normal healthy subjects that expressed
the chemokine receptor CXCR3 was significantly reduced
(Figures 6 A,B, P<0.05). However, such an effect was not
observed following incubation with medium conditioned by
the control cell line MIHA for 20 h (Figure 6). Furthermore, the
proportion of CD4+ and CD8+ T cells from normal healthy
subjects that expressed the chemokine receptor CXCR3 was
significantly reduced following incubation with medium
supplemented with 10% serum from HCC patients for 24 h
(Figures 7 A,B, P<0.05). Such an effect was not observed
following incubation with medium containing the serum of
normal subjects for 24 h (Figure 7).
Migration of T lymphocytes toward chemokine IP-10 was
reduced in HCC patients
To determine whether the reduced CXCR3 expression on
lymphocytes was biologically significant, we examined the
migration of T cells toward the corresponding chemokine ligands.
As shown in Figure 8A, CD4+ T cells from patients with HCC
failed to display a significant migratory response to the CXCR3
ligand IP-10. In contrast, CD4+ T cells from healthy controls
exhibited a significant chemotactic response to IP-10 (P<0.01).
Similar results were obtained when CD8+ T cells derived from
HCC cases were studied, but no significant migratory activity
toward IP-10 was observed (Figure 8B). In contrast to HCC
cases, CD8+ T cells from normal controls displayed a significant
chemotactic response to IP-10 (Figure 8B, P<0.01).
Figure 5  Early activation and later inhibition of ERK phos-
phorylation induced by tumor cell culture supernatants in
lymphocytes from normal controls. A total of 5×106 freshly
isolated lymphocytes were incubated with 500 L of culture
supernatants or IP-10 at 100 nmol/L in a 37 ℃ incubator for
either 10 min or overnight. The cells were lysed and ERK
phosphorylation was determined by Western blotting. The
SDS-PAGE profile represents one experiment out of three.
Figure 4  Secretion of chemotactic factors by Hep3B cells for lymphocytes from healthy subjects in vitro. The ability of culture
supernatants from Hep3B cells to induce CD4+ (A) and CD8+ (B) T cell chemotaxis was tested by chemotactic experiments as
described in Materials and Methods. To test the effect of blocking CXCR3 on the chemotactic response of lymphocytes to Hep3B
culture supernatants, lymphocytes were pretreated with anti-CXCR3 monoclonal antibody or IgG control before the chemotaxis
assay. Results are expressed as migration index, calculated as described in Materials and Methods.
Figure 6  Expression of CXCR3 on normal CD4+ or CD8+ T cells incubated with unconditioned medium or medium conditioned
with the tumor cell lines or a control cell line. Cell culture supernatants conditioned for 3 d by the HCC cell lines Hep3B, HuH-
7 or the control cell line MIHA were collected. Freshly isolated normal PBLs were incubated in unconditioned or conditioned
medium for 20 h and T cell expression of CXCR3 was assessed by flow cytometry. Diminished CXCR3 expression on CD4+ T cells
(A) and CD8+ T cells (B) was observed following incubation in HCC cell line supernatants whilst the control cell line supernatant
had no significant effect. Data represent the median and the 25th, 75th and 90th percentiles, n = 8, aP<0.05 vs medium control.
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DISCUSSION
The low proportion of HCC exhibiting a significant lymphocyte
infiltration compared with some other cancers is an intriguing
phenomenon, and might well be related to the generally poor
prognosis of HCC patients[6,7]. In this study, we attempted to
elucidate the role of chemokines and chemokine receptors in
the regulation of lymphocyte migration in HCC. We measured
the serum levels of chemokines in HCC patients and compared
them to normal control subjects. The serum levels of IP-10 and
Mig were significantly elevated in HCC patients. Furthermore,
serum IP-10 level was significantly positively correlated with
serum Mig level in HCC cases. In addition, the IP-10 level in
tumor tissues was significantly higher than that in noninvolved
adjacent liver tissues. Lastly, analysis of cell culture supernatants
indicated that HCC tumor cell lines secreted a significant amount
of IP-10 and Mig that was functionally active in chemotactic
assays.
    The interaction between chemokines and chemokine
receptors is a key determinant for the selectivity of local
immunity. We therefore investigated whether tumor-cell-derived
chemokines acted to direct lymphocyte movements. Our data
indicated that the tumor cell line Hep3B secreted functional
chemotactic factors for normal lymphocytes. Furthermore,
function blocking monoclonal antibody to CXCR3 could
partially inhibit lymphocyte chemotaxis, indicating the
involvement of ligands to CXCR3. Treatment of lymphocytes
with IP-10 resulted in rapid ERK phosphorylation, but the
activation was transient and rapidly desensitized[30].  Interestingly,
we found that exposure of normal lymphocytes to tumor cell
culture supernatants resulted in rapid phosphorylation of
tyrosine residues on ERK but inhibition of ERK activation after
prolonged stimulation, an effect that may well be secondary to
the presence of IP-10 in the tumor cell supernatant. It was
previously documented that phosphorylation of ERK was linked
to cell migration, adhesion, proliferation and survival[31,32].
Therefore, it is possible that sustained exposure of lymphocytes
to IP-10 secreted by tumors might inhibit lymphocyte function.
To investigate this hypothesis, we analyzed the chemokine
receptor expression following incubation of normal PBLs with
tumor cell conditioned medium. This treatment led to the
reduction in the proportion of both CD4+ and CD8+ T cells with
surface expression of CXCR3, thereby suggesting that HCC
might secret factors that reduce chemokine receptor expression
on PBLs. Previous work indicated that the chemokine receptor
CXCR3 on PBLs could be modulated by internalization and
desensitization following interaction with their chemokine
ligands[33], and that chemokine receptors could be desensitized
by either high levels of chemokines or prolonged exposure to
chemokines[34]. We therefore speculated that the reduced surface
expression of CXCR3 on normal PBLs after exposure to tumor-
cell-conditioned medium might partially be due to the
desensitization of lymphocytes by tumor-cell-derived chemokines.
To further test this hypothesis, we also examined the effect of
serum from either HCC patients or normal control subjects upon
lymphocyte CXCR3 expression. Our data indicated that normal
lymphocytes exhibited a reduced lymphocyte expression of
CXCR3 after treatment with HCC patient serum compared to
normal serum. These data resonate with the work by Kurt et al[35]
who pointed out that T cells from naïve animals demonstrated
a greater chemotactic response to tumor-derived chemokines
Figure 7  Expression of CXCR3 on normal CD4+ or CD8+ T cells incubated with medium supplemented with 10% serum from
either HCC patients or normal subjects. Normal T cells cultured in the full medium with 10% FCS served as medium control.
After 24 h, surface expression of CXCR3 on T cells was assessed by flow cytometry. Diminished CXCR3 expression on CD4+ T
cells (A) and CD8+ T (B) cells was observed after incubation with HCC patient serum compared with normal serum. Data
represent the median and the 25th, 75th and 90th percentiles, n = 9, aP<0.05.
Figure 8  Chemotactic responsiveness of CD4+ T cells and CD8+T cells to IP-10. CD4+ T cells and CD8+T cells from HCC patients
did not exhibit a significant chemotactic response toward IP-10 compared to CD4+ T cells and CD8+T cells from normal subjects.
Results are expressed as migration index, calculated as described in Materials and Methods. Data are the median and the 25th, 75th
and 90th percentiles, n = 7, aP<0.05.
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P = 0.009
compared to T cells from tumor-bearing mice, suggesting the
presence of chemokine receptor desensitization in the tumor
bearing mice.
     Undoubtedly, there is an inadequate induction of tumor
immunity in HCC patients. Indeed, the function of peripheral
blood dendritic cells was also decreased in this patient group[36].
We demonstrated that CXCR3 expression on PBLs from HCC
patients was reduced compared to that of healthy control
subjects[37]. Furthermore, we demonstrated that the reduced
CXCR3 expression in HCC correlated with decreased migratory
responses of CD4+ and CD8+ T cells toward chemokine IP-10.
Chemokine receptor expression level is critically important in
lymphocyte function[29], and our results therefore indicated
that impaired migratory function of peripheral lymphocytes in
HCC patients was due to decreased chemokine receptor
expression. Despite the presence of lymphocyte recruitment
likely mediated by CCR5, CCR6 and CXCR3[37], the levels of
infiltrating lymphocytes might still be inadequate. Indeed,
elevated levels of circulating CXCR3 ligands can act to induce
peripheral desensitization of circulating T cells and this could
limit further on-going lymphocyte recruitment. This may well
underlie the somewhat paradoxical combination of chemokine
production by HCC tumor tissue in the absence of marked
lymphocytic infiltration of HCC.
      In conclusion, this study demonstrated elevated serum levels
of IP-10 and Mig in HCC patients as well as increased IP-10
concentration in tumor tissues compared to adjacent non-tumor
tissues. These findings are associated with the reduced
migratory function of peripheral blood T cells in HCC patients
and our data suggest that this is likely to be a consequence of
desensitization of the chemokine receptor CXCR3 by prolonged
exposure to a high level of circulating CXCR3 ligands. T-cell
based immunotherapy provides a great future potential for
treatment of cancer including HCC[38]. The insufficient anti-
tumor response in HCC patients may in part lie in the deficient
expression of appropriate chemokine receptors by T cells.
Chemokines are expressed by a range of tumors including HCC
and may serve as suitable targets for directing specific T cells
toward the tumor[39]. Chemokine receptors such as CCR5 play a
critical role in T cell migration to cancer and subsequent
induction of tumor regression[40]. However, the reduced expression
of specific chemokine receptors on peripheral lymphocytes in HCC
patients and the resultant loss of lymphocyte responsiveness to
tumor-derived chemokines may partially ‘blind’ them to the
presence of life threatening tumors. The clinical challenge is
therefore to find novel approaches to augment the specific
chemokine receptor expression of lymphocytes in HCC patients.
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